Evidence map›Paper›PMID 19892791›Full record

SynthesisBMJ (Clinical research ed.)2009

Evaluating the causal relevance of diverse risk markers: horizontal systematic review.

Hannah Kuper, Amanda Nicholson, Mika Kivimaki, Amina Aitsi-Selmi, Gianpiero Cavalleri, John E Deanfield, Peter Heuschmann, Xavier Jouven, Sofia Malyutina, Bongani M Mayosi and 6 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 5 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 5 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Status and Determinants of Symptoms of Anxiety and Depression among Food Delivery Drivers in Shanghai, China.International journal of environmental research and public health · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Stress and cardiovascular disease.Nature reviews. Cardiology · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 7 countries.

Hannah KuperEpidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT. hannah.kuper@lshtm.ac.uk
Amanda Nicholson
Mika Kivimaki
Amina Aitsi-Selmi
Gianpiero Cavalleri
John E Deanfield
Peter Heuschmann
Xavier Jouven
Sofia Malyutina
Bongani M Mayosi
Susanna Sans
Troels Thomsen
Jacqueline C M Witteman
Aroon D Hingorani
Debbie A Lawlor
Harry Hemingway
University College London · GBBeaumont Hospital · IECharité - Universitätsmedizin Berlin · DEErasmus MC · NLGlostrup Hospital · DKGreat Ormond Street Hospital · GBInserm · FRUniversity of Cape Town · ZAUniversity of London · GB

Funding

British Heart Foundation FS 05/125British Heart Foundation RG/07/008/23674Department of HealthMedical Research Council G0100222Medical Research Council G0600705Medical Research Council G19/35Medical Research Council G8802774Wellcome Trust
6 · The paper itself

Abstract

objectivesTo develop a new methodology to systematically compare evidence across diverse risk markers for coronary heart disease and to compare this evidence with guideline recommendations.

design"Horizontal" systematic review incorporating different sources of evidence. DATA SOURCES: Electronic search of Medline and hand search of guidelines. Study selection Two reviewers independently determined eligibility of studies across three sources of evidence (observational studies, genetic association studies, and randomised controlled trials) related to four risk markers: depression, exercise, C reactive protein, and type 2 diabetes. Data extraction For each risk marker, the largest meta-analyses of observational studies and genetic association studies, and meta-analyses or individual randomised controlled trials were analysed.

resultsMeta-analyses of observational studies reported adjusted relative risks of coronary heart disease for depression of 1.9 (95% confidence interval 1.5 to 2.4), for top compared with bottom fourths of exercise 0.7 (0.5 to 1.0), for top compared with bottom thirds of C reactive protein 1.6 (1.5 to 1.7), and for diabetes in women 3.0 (2.4 to 3.7) and in men 2.0 (1.8 to 2.3). Prespecified study limitations were more common for depression and exercise. Meta-analyses of studies that allowed formal Mendelian randomisation were identified for C reactive protein (and did not support a causal effect), and were lacking for exercise, diabetes, and depression. Randomised controlled trials were not available for depression, exercise, or C reactive protein in relation to incidence of coronary heart disease, but trials in patients with diabetes showed some preventive effect of glucose control on risk of coronary heart disease. None of the four randomised controlled trials of treating depression in patients with coronary heart disease reduced the risk of further coronary events. Comparisons of this horizontal evidence review with two guidelines published in 2007 showed inconsistencies, with depression prioritised more in the guidelines than in our review.

conclusionsThis horizontal systematic review pinpoints deficiencies and strengths in the evidence for depression, exercise, C reactive protein, and diabetes as unconfounded and unbiased causes of coronary heart disease. This new method could be used to develop a field synopsis and prioritise future development of guidelines and research.

Indexed as

BiasConfounding Factors, EpidemiologicCoronary DiseaseC-Reactive ProteinDepressive DisorderDiabetes Mellitus, Type 2Diabetic AngiopathiesExerciseFemaleGenetic MarkersGenotypeHumansMalePolymorphism, GeneticPractice Guidelines as TopicRandomized Controlled Trials as TopicC-Reactive ProteinGenetic Markers

Identifiers

PMID19892791
PMCPMC2773829
OpenAlexW1986706743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.